[
    [
        {
            "time": "",
            "original_text": "科技創新和成果轉化難？資本這樣為醫藥企業破題丨走進行業先鋒·解密高質量發展（二）",
            "features": {
                "keywords": [
                    "科技創新",
                    "成果轉化",
                    "資本",
                    "醫藥企業",
                    "高質量發展"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫療",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "科技創新和成果轉化難？資本這樣為醫藥企業破題丨走進行業先鋒·解密高質量發展（二）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]